Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024
Stock Information for Assertio Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.